It has been reported that enrichment of Bacteriodes and reduction of members of the Porphydomonaceae family are associated with tumor growth in mice.[50] Our current observation that administration of ETO-Cur-TRF decreased Bacteroides by about 45% suggests that inhibition of tumor growth in response to the current combinatorial treatment could partly be attributed to reduction in Bacteroides. Here, RUNX1T1 is linked to neoplasm.